Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $88.8108 (-2.57%) ($88.1390 - $91.2805) on Thu. Oct. 18, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 41 | Latest Price | $88.8108(-2.57%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(50%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.765% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
1 - 5 Day Possible Target | $87.06(-1.97%) | Resistance Level | $91.23 | 5 Day Moving Average | $89.69(-0.98%) | 10 Day Moving Average | $90.48(-1.84%) | 20 Day Moving Average | $91.23(-2.65%) | To recent high | -8% | To recent low | 2.2% | Market Cap | $156.687b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |